We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$5.96M
Cap. Flow %
-2.51%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19

Top Buys

Rank Stock Value
1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

Rank Sector Weight
1 Healthcare 32.63%
2 Materials 25.45%
3 Miscellaneous 11.79%
4 Financials 10.86%
5 Real Estate 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLMT icon
1
Calumet Specialty Products
CLMT
$4.2B
$55.4M 23.31%
4,325,000
– –
DCGO icon
2
DocGo
DCGO
$39.3M
$13.9M 5.84%
1,400,000
– –
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.19T
$10.8M 4.54%
112,220
– –
APO icon
4
Apollo Global Management
APO
$79.7B
$10.5M 4.4%
225,000
– –
LGND icon
5
Ligand Pharmaceuticals
LGND
$5.59B
$9.9M 4.17%
184,345
– –
FBRT
6
Franklin BSP Realty Trust
FBRT
$703M
$9.25M 3.89%
859,047
– –
FTAI icon
7
FTAI Aviation
FTAI
$20B
$6.37M 2.68%
425,000
-72,675
-15% -$1.25M
PFE icon
8
Pfizer
PFE
$159B
$6.28M 2.64%
143,500
– –
MITAW
9
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M 2.4%
495,000
– –
AGAC.WS
10
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$5.18M 2.18%
450,750
– –
MDWT
11
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$5.16M 2.17%
390,241
+36,304
+10% +$497K
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$137B
$4.92M 2.07%
17,000
– –
JNJ icon
13
Johnson & Johnson
JNJ
$646B
$4.05M 1.7%
24,800
– –
CTIC
14
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.3M 1.39%
566,687
– –
EIGR
15
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.08M 1.3%
13,643
– –
JAZZ icon
16
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.99M 1.26%
22,411
– –
GLHAW
17
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 1.21%
250,000
– –
KW
18
DELISTED
Kennedy-Wilson Holdings
KW
$2.71M 1.14%
175,000
– –
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.69M 1.13%
43,490
– –
ABBV icon
20
AbbVie
ABBV
$451B
$2.69M 1.13%
20,037
– –
XENE icon
21
Xenon Pharmaceuticals
XENE
$5.81B
$2.15M 0.9%
59,500
– –
JPM icon
22
JPMorgan Chase
JPM
$951B
$2.13M 0.9%
20,385
– –
VXX icon
23
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$133M
$2.12M 0.89%
6,250
– –
MRK icon
24
Merck
MRK
$366B
$2.11M 0.89%
24,500
– –
MSAC
25
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$1.98M 0.83%
200,000
– –
1
2 3 4 5

Similar funds

GFL
Granite FO LLC Bedford, New Hampshire $189M AUM 56.18% 1-Year Est. Return
SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FSBI
Fearless Solutions (Best Invest) San Antonio, Texas $189M AUM 32.69% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Materials and Miscellaneous.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.